🇺🇸 FDA
Patent

US 7928057

Peptide for inhibition of calcineurin, nucleic acid, antibody, and diagnostic and therapeutic methods of use

granted A61PA61P1/04A61P11/06

Quick answer

US patent 7928057 (Peptide for inhibition of calcineurin, nucleic acid, antibody, and diagnostic and therapeutic methods of use) held by Julius-Maximilians-Universitat Wurzburg expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Julius-Maximilians-Universitat Wurzburg
Grant date
Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61P, A61P1/04, A61P11/06, A61P17/06, A61P19/02